1. Bowdish M.E., Arcasoy S. M., Wilt J.S. et al. Surrogate markers and risk factors for chronic lung allograft dysfunction. Am. J. Transplant. - 2004. -N. 4. - P. 1171-1178.
2. Cahill B.C., Somerville K.T., Crompton J.A. et al. Early experience with sirolimus in lung transplant recipients with chronic allograft rejection. - J. Heart Lung Transplant. - 2003. - N. 22. - P. 169-176.
3. Cantu E., Appel J.Z., Hartwig M.G. et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. - Ann. Thorac. Surg. - 2004. -N. 78. - P. 1142-1151.
4. Cooper J., Billingham M., Egan T. et al: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Transplantation. - J. Heart Lung Transplant. - 1993. - N. 12. - P. 713-716.
5. Davis R.D., Lau C., Eubanks S. et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. - J. Thorac. Cardiovasc. Surg. - 2003. - N. 125. - P. 533-542.
6. de Perrot M., Chaparro C., McRae K. et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. - J. Thorac. Cardiovasc. Surg. - 2004. - N. 127. - P. 1493-1501.
7. Estenne M., Maurer J.R., Boehler A. et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. - J. Heart Lung Transplant. - 2002. - N. 21. - P. 297-310.
8. Estenne M., Hertz M.I. Bronchiolitis obliterans after human lung transplantation. - Am. J. Respir. Crit. Care Med. - 2002. - N. 166. -P. 440-444.
9. Glanville A.R., Estenne M. Indications, patient selection and timing of referral for lung transplantation. - Eur. Respir. J. - 2003. - N. 22. - P. 845-852.